Learn, Analyse & Invest
only with
only with
+91
Download Orca
Kabra Drugs Ltd.
Kabra Drugs
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹61.71 Cr.
| EX-Date | Purpose |
|---|---|
| 29 06 2021 | Audited Results |
| 14 08 2021 | Quarterly Results |
| 02 09 2021 | Inter alia, to consider and approve the following: - 1. To approve the Notice to Convene 32nd Annual General Meeting of the Company 2. To appoint director in place of Ms. ANANTHKUMAR SHILPA, who retires by rotation and is eligible, offers herself for Re-appointment 3. To appoint director in place of Mr. BANGALORE RAJEEVALOCHANA PRASANNA, who retires by rotation and is eligible, offers himself for Re-appointment |
| 13 11 2021 | Quarterly Results |
| 12 02 2022 | Quarterly Results |
| 14 02 2022 | Quarterly Results (Revised) |
| 10 03 2022 | KABRA DRUGS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/03/2022 ,inter alia, to consider and approve This is to inform you that a meeting of the Board of Directors of the Company will be held on Thursday, March 10, 2022 at the Company s Registered Office to take on record the following matter: 1. Consider the resignation of Company Secretary and Compliance Officer Radhika Dammani. 2. Any other matter with the permission of the Chair. |
| 18 03 2022 | Inter alia, to take on record the following matter: 1. Appointment of Mr. Pritam Paul as Company Secretary and Compliance Officer of the Company. 2. Any other matter with the permission of the Chair. |
| 06 05 2022 | Inter alia, to take on record the following matter: 1. Resignation of Pritam Paul from Company Secretary and Compliance Officer 2. Appointment of Nidhi Bhaskar as Company Secretary and Compliance Officer 3. Any other matter with the permission of the Chair. |
| 30 05 2022 | Quarterly Results & Audited Results |
| 09 06 2022 | Inter alia, to take on record the following matter: 1. Appointment of Mr. K.N. Anand and Mrs. A. Anitha as an Additional Director to broad base the Board. 2. Any other matter with the permission of the Chair. |
| 14 07 2022 | Inter alia, to take on record the following matter: 1. Resignation of Nidhi Mahajan from Company Secretary and Compliance Officer 2. Appointment of Monika Nishant Lal Sanwal as Company Secretary and Compliance Officer 3. Any other matter with the permission of the Chair. |
| 13 08 2022 | Quarterly Results |
| 02 09 2022 | Inter alia, to consider and approve the following: - 1. To fix the Date, Time and Venue to convene the Annual General meeting of the Company & the draft Notice calling the AGM. 2. To announce the Book Closure Dates. 3. Any other Agenda with the permission of the chair. |
| 02 11 2022 | Inter alia, to take on record the following matter: 1. Consider the resignation of Independent Director Ramachandran Muralidharan 2. Any other matter with the permission of the Chair. |
| 14 11 2022 | Quarterly Results |
| 14 02 2023 | Quarterly Results |
| 30 05 2023 | Audited Results |
| 14 08 2023 | Quarterly Results |
| 02 09 2023 | Inter alia, to consider and approve the following: - 1. To fix the Date, Time and Venue to convene the Annual General meeting of the Company & the draft Notice calling the AGM. 2. To announce the Book Closure Dates. 3. Any other Agenda with the permission of the chair. |
| 13 11 2023 | Quarterly Results |
| 15 12 2023 | Inter alia, to take on record the following matter: 1. To Broad base the board by appointing two new directors 2. To discusses about expansion and brining in new business 3. Any other agenda with the permission of the chair |
| 23 01 2024 | Inter alia to consider and approve the following matters: To consider and approve proposal of fund raising by issue of equity shares or any other permitted mode, through Preferential Allotment/Private Placement basis to the Non-Promoter / Public Category of investors in accordance with the provision of the Companies Act, 2013 and SEBI (Issue of Capital and Disclosure Requirements Regulation, 2018, as amended, subject to regulatory or statutory approvals as may be required including the approval of the shareholders of the Company. Increase in Authorised Share Capital of the company from Rs.5 crores to Rs.16 Crores. Any other matter with permission of the Chairman. |
| 14 02 2024 | Quarterly Results |
| 04 11 2024 | Inter alia, to consider and evaluate proposal for raising of funds by the Company, by way of inter alia, issue of equity shares or any other equity linked instruments or securities including convertible preference shares/ fully or partly convertible debentures or by way of a composite issue of non-convertible debentures and warrants entitling the warrant holder(s) to apply for equity shares, or any other eligible securities through inter alia, a private placement (including one or more qualified institutions placements) or further public issue of equity/ debt securities, preferential issue or a rights issue or through any other permissible mode under applicable laws and / or combination thereof, as may be considered appropriate, subject to such statutory/regulatory/other approvals as may be required, including the approval of the members, to seek their consent for such fund raising and to approve ancillary actions for such fund raising. |
| 14 11 2024 | Quarterly Results |
| 04 12 2024 | Inter alia to consider and approve the following matters: 1. To consider and approve proposal of fund raising by issue of equity shares or any other permitted mode, through Preferential Allotment/Private Placement / Convertible warrants basis to the Promoter /Non-Promoter / Public Category of investors in accordance with the provision of the Companies Act, 2013 and SEBI (Issue of Capital and Disclosure Requirements Regulation, 2018, as amended, subject to regulatory or statutory approvals as may be required including the approval of the shareholders of the Company. 2. Increase in Authorised Share Capital of the company from 2,00,00,000 shares to 3,00,00,000 of Rs. 10 each. 3. To Consider shifting of Registered office of the company from Shop 208, Swadesh Bhavan, 2 Press Complex, AB Road, Indore, Madhya Pradesh 452011to No.3, 1st Floor, Swaminathan Street, West Mambalam, Chennai ? 600033. 4. Any other matter with permission of the Chairman. |
| 14 02 2025 | Quarterly Results |
| 30 05 2025 | Audited Results |
| 18 06 2025 | Inter alia, to take on record the following matter: 1. New acquisition 2. New drug license for a Chennai office 3. Diversification by creating new subsidiary 4. Any other agenda with the permission of the chair |
| 06 08 2025 | Inter alia, to take on record the following matter: 1. To discusses about expansion and new business opportunities 2. To Broad base the board and to bring in new technical people 3. Any other agenda with the permission of the chair |
| 14 08 2025 | Quarterly Results |
| 02 09 2025 | Inter alia, to consider and approve the following: - 1. To approve Director?s Report and Corporate Governance Report for the financial year 2024 -25; 2. To approve closure of Register of Members and Share Transfer Books of the Company for Annual General Meeting (AGM) purpose; 3. To approve the Cut-off date to record the entitlement of shareholders to cast their votes for the AGM; 4. To consider and approve the appointment of Internal Auditors for the financial year 2025-26 of the Company; 5. To fix the Date, Time and Venue to convene the Annual General meeting of the Company & the draft Notice calling the AGM. 6. To consider and approve appointment of scrutinizer for AGM purpose; 7. To discuss acquire new property for office purpose 8. Any other agenda with the permission of the chair. |
| 08 10 2025 | Inter alia, to consider the following matter:- 1. Consider and approve the final draft of the Share Purchase Agreement (SPA) in relation to the acquisition of AMR PHARMA INDIA PRIVATE LIMITED. 2. To Broad base the board and to bring in new technical people 3. Any other agenda with the permission of the chair |
| 13 11 2025 | Quarterly Results |
| 28 11 2025 | Inter alia, to transact the business as given below: - 1. To recommend the appointment of Ms. Ritu Tiwari as Director of the Company. 2. To recommend the appointment of Ms. Nikita Sinha as Director of the Company. 3. To sign an agreement with MR FRANCHISE to appoint around 200 channel partner throughout the Country for expansion. 4. To consider and approve appointment of scrutinizer for EGM purpose. 5. To fix the Date, Time and Venue to convene the Extra-Ordinary General meeting of the Company & the draft Notice calling the EGM. 6. Any other agenda with the permission of the chair |
| 01 01 2026 | Inter alia, to consider and approve the following strategic business items: 1. Change of Name of the Company The Board will consider a proposal to change the name of the Company to better reflect its new business direction and brand identity, subject to the approval of shareholders and the Ministry of Corporate Affairs. 2. Strategic Acquisitions The Board will evaluate and consider the proposal for the acquisition of: Pharmaceutical formulation Company A Medical Equipment manufacturing company. An Electric Vehicle (EV) manufacturing entity. Steel / Tin Sheets manufacturing and trading Company This move is aimed at inorganic growth and expanding the Company?s footprint in high-growth sectors. 3. Alteration of the Main Objects (MOA) To facilitate diversification, the Board will discuss the amendment of the Main Objects clause of the Memorandum of Association (MOA) to include: Electric Vehicle (EV) manufacturing and distribution. Steel / Tin Sheets manufacturing and trading. Solar Energy equipment manufacturing and power generation. |
| 13 02 2026 | Quarterly Results |
| 07 03 2026 | Inter-alia, to consider and approve the following business:- 1. Change of Name: To consider and approve the proposal for changing the name of the company, subject to the approval of shareholders and the Ministry of Corporate Affairs (MCA). 2. Global Expansion: To discuss and approve the strategic expansion of business operationsin Indonesia and Canada. 3. Chairman?s Permission: To consider any other business matter with the permission of the Chair. |
| 21 04 2026 | Inter-alia, to consider and approve the following business: 1. To consider and approve the appointment of Ms. Monam Kapoor (DIN: 09278005) as Additional Director, Designated as Non-Executive and Independent Director of the Company. 2. To facilitate diversification, the Board will discuss the amendment of the Main Objects clause of the Memorandum of Association (MOA) to include: a. Drones & Defence equipment manufacturing and distribution. b. Hospital, E- Pharmacy & Medical equipment manufacturing and distribution. c. All types of dairy products manufacturing. d. Intelligence (AI) technologies, Software & Hardware products manufacturing. e. Hospitality and allied service sectors. f. Establishing and running agro farms & manufacturing and trading of all kinds of agro products. 3. To consider and approve Notice of Postal Ballot for the above stated matter and such other matters. 4. To fix Cut-off date and E-voting schedule for conducting Postal Ballot process. 5. To appoint scrutinizer to scrutinize the entire Postal Ballot process in a fair and transparent manner. 6. Any other agenda with permission of chair |
| 06 05 2026 | Inter-alia, to consider and approve the following business: 1. Pharmaceutical Expansion: To discuss pharmaceutical manufacturing and marketing expansion of own brands through strategic channel partners. 2. Defense & AI Integration: To evaluate opportunities in defense manufacturing through the application of Artificial Intelligence (AI) Technologies. 3. Any other agenda with permission of chair. |
News
No News data available
